Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...

For procedures like BBL, fat is usually extracted from the patient via liposuction and then reinjected into the desired area ...

Samsung Bioepis Co., Ltd. today announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', a biosimilar referencing Stelara 1 (ustekinumab), developed by Samsung ...

Novo Nordisk carries a Zacks Rank #5 (Strong Sell), whereas Amgen carries a Zacks Rank #3 (Hold) at present, which makes AMGN ...

NASHVILLE, Tenn. — UPDATE (12/10): On Wednesday, Knox County Chancellor John F. Weaver ordered the release of the expiration dates for the lethal injection drugs used in the executions of Oscar Smith ...

Johnson & Johnson JNJ faces several challenges, like potential losses from expiring drug patents, ongoing legal battles related to its talc powder and broader macroeconomic uncertainties. Here, we ...

KNOXVILLE, Tenn. — The state of Tennessee has turned over to a Knox County chancellor information about its supply of a lethal injection drug, after the chancellor this week turned down the state's ...

Ustekinumab had a market value of approximately $17.1 billion for the 12 months ending December 2024, per IQVIA. Hikma is acquiring Insys' unit dose nasal and sublingual spray manufacturing equipment, ...

Mark Cuban Cost Plus Drug Co. has added Starjemza, a biosimilar to Johnson & Johnson’s Stelara (ustekinumab), to its portfolio. The company, co-founded by billionaire entrepreneur Mark Cuban, is ...

OpenAI unveiled its Atlas AI browser this week, and it’s already catching heat. Cybersecurity researchers are particularly alarmed by its integrated “agent mode,” currently limited to paying ...